Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis

Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis

(1) Background: In recent years, immunotherapy has revolutionized the treatment landscape of non-small cell lung cancer (NSCLC), representing a therapeutic breakthrough in this field. Antacid agents such as proton pump inhibitors (PPIs) and histamine-2-receptor antagonists (H2RAs) are commonly presc...

Full description

Bibliographic Details
Main Authors: Alessandro Rizzo, Antonio Cusmai, Francesco Giovannelli, Silvana Acquafredda, Lucia Rinaldi, Andrea Misino, Elisabetta Sara Montagna, Valentina Ungaro, Mariagrazia Lorusso, Gennaro Palmiotti
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Cancers
Subjects:
antiacid
proton pump inhibitors
immunotherapy
non-small cell lung cancer
immune checkpoint inhibitors
Online Access:https://www.mdpi.com/2072-6694/14/6/1404

Internet

https://www.mdpi.com/2072-6694/14/6/1404

Similar Items